Trials / Conditions / B-Cell Acute Lymphoblastic Leukemia, Adult

B-Cell Acute Lymphoblastic Leukemia, Adult

9 registered clinical trials studyying B-Cell Acute Lymphoblastic Leukemia, Adult — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Study of Inotuzumab and Blinatumomab in People With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia NCT07313852	Memorial Sloan Kettering Cancer Center	Phase 2
Not Yet Recruiting	Autologous Bedside CD19 CAR T-cell Therapy for B-ALL NCT07277504	The General Hospital of Western Theater Command	EARLY_Phase 1
Not Yet Recruiting	Allogeneic UCB-derived CAR-T for B-ALL NCT07256353	The General Hospital of Western Theater Command	EARLY_Phase 1
Active Not Recruiting	Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B- NCT07199855	Zhejiang University	Phase 2
Recruiting	Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leuke NCT06696833	The First Affiliated Hospital of Soochow University	EARLY_Phase 1
Completed	Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph+ B-ALL NCT04788472	Zhejiang University	Phase 2
Unknown	Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph- B-ALL NCT04740203	Zhejiang University	Phase 1 / Phase 2
Active Not Recruiting	CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies NCT04214886	Loyola University	Phase 1
Completed	Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts NCT03160079	University of California, San Diego	Phase 1 / Phase 2